Characterization of lysine crotonylation-related lncRNAs for prognostic assessment and immune response in glioma
Our study demonstrates that LCRlncRNAs are closely linked to glioma prognosis, immune microenvironment remodeling, and therapeutic response. The LCRlncRNA-based risk model provides a promising tool for prognostic evaluation and personalized therapy design in glioma.
Authors
- Junyu Qian (ORCID: https://orcid.org/0009-0009-9924-0074)
- Yun Wu (ORCID: https://orcid.org/0000-0001-5347-0098)
- Hongmei Sheng
- Haotian Qin (ORCID: https://orcid.org/0000-0001-8898-921X)
- Xueyong Huang (ORCID: https://orcid.org/0000-0001-8995-9274)
- Juan Xu (ORCID: https://orcid.org/0000-0002-3709-4165)
- Zhonghao Gui
- Miaomiao Song
- Yingying Wang (ORCID: https://orcid.org/0000-0003-4363-8779)
- Feifei Wang (ORCID: https://orcid.org/0000-0003-2893-1440)
Institutions
- Anhui Medical University (CN)
- Anhui University of Traditional Chinese Medicine (CN)
- Chaohu Hospital of Anhui Medical University (CN)
- Peking University Shenzhen Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- Lu'an First People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.3389/fphar.2025.1573694
- Citations
- 3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 2.81